U.S. to Begin Paying UN Dues as Financial Crisis Spurs Push for Reforms 
Minnesota Judge Rejects Bid to Halt Trump Immigration Enforcement in Minneapolis 
Trump to Announce New Federal Reserve Chair Pick as Powell Replacement Looms 
Trump Appoints Colin McDonald as Assistant Attorney General for National Fraud Enforcement 
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025 
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Pentagon and Anthropic Clash Over AI Safeguards in National Security Use 
Palantir Stock Jumps After Strong Q4 Earnings Beat and Upbeat 2026 Revenue Forecast 
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors 
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
U.S. Justice Department Removes DHS Lawyer After Blunt Remarks in Minnesota Immigration Court 
Trump Signs “America First Arms Transfer Strategy” to Prioritize U.S. Weapons Sales 
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 
U.S. President Donald Trump has signed an executive order aimed at expanding the use of artificial intelligence (AI) in pediatric cancer research. The order provides an additional $50 million in research grants to accelerate progress in finding cures for childhood cancers, according to White House officials.
This move builds on the National Cancer Institute’s (NCI) Childhood Cancer Data Initiative, a decade-long, $500 million program launched in 2019 to collect and share vital data on pediatric cancers. Michael Kratsios, director of the White House Office of Science and Technology Policy, highlighted that childhood cancer remains the leading cause of disease-related deaths among children in the United States, with cases rising more than 40% since 1975.
Kratsios noted that advances in AI can now be harnessed to sharpen diagnoses, improve clinical trials, fine-tune treatment strategies, and enhance prevention methods. Data gathered through the NCI initiative is expected to empower researchers with new tools to tackle the complexity and diversity of pediatric cancers.
In addition to the $50 million in grants, the National Institutes of Health (NIH) will double its commitment by investing another $50 million. This funding aims to attract leading scientific teams through competitive research opportunities. Further investments are also anticipated to strengthen ongoing initiatives.
The announcement comes despite Trump’s 2026 budget proposal, which suggested a 37% cut to the NCI budget. Lawmakers in both the House and Senate, however, have pushed back against these cuts, and budget negotiations remain ongoing.
Globally, the World Health Organization reports that around 400,000 children and adolescents are diagnosed with cancer each year. While advances in adult cancer research have surged with AI, pediatric cancer research has lagged due to challenges like cancer rarity, diversity, and ethical concerns over patient data protection.
By reinforcing funding and leveraging AI, the administration aims to close this gap and accelerate life-saving innovations in childhood cancer treatment.
